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Abstract
AIM: To disclose geographic differences in genetic 
changes involved in gallbladder carcinogenesis between 
two distinct high-incidence areas of Japan and Hungary.
METHODS: We examined 42 cases of gallbladder 
carcinoma: 22 Japanese and 20 Hungarian cases. p53  
mutations at exons 5 to 8 and K-ras  mutations at codon 
12 were tested by direct sequencing. Microsatellite 
instability was determined from fluorescent dye-labeled 
PCR amplifications of five-microsatellite markers (BAT-25 , 
BAT-26 , D2S123, D5S346, and D17S250).
RESULTS: Mutations of p53  were detected in 11 of 22 
Japanese cases and 6 of 18 Hungarian cases (11/22 vs  
6/18, P  = 0.348). Transition at CpG sites was found in 
none of 11 Japanese cases and 2 of 6 Hungarian cases; 
the difference was marginally significant (0/11 vs  2/6, 
P  = 0.110). K-ras  mutations were detected in only one 
of the Hungarian cases. Eight of 19 (42.1%) Japanese 
cases were MSI-high (presence of novel peaks in more 
than one of the five loci analyzed), whereas only 1 of 15 
(6.7%) Hungarian cases was MSI-high (P  = 0.047).
CONCLUSION: It appears that the p53  mutations and 
MSI differ in patients with gallbladder carcinoma between 
two distinct high-incidence areas. Geographic variation 
might exist in the process of gallbladder carcinogenesis.
© 2008 WJG. All rights reserved.
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INTRODUCTION
Although considerable progress has been made regarding 
the molecular pathogenesis of  human neoplasms such 
as colorectal carcinoma[1,2], pancreatic carcinoma[3,4], and 
breast carcinoma[5,6], there is only limited information 
about the genetic changes involved in gallbladder 
carcinogenesis[7,8]. Gallbladder carcinoma shows striking 
geographic and ethnic variation[9,10]. The high-incidence 
areas are scattered throughout the world: Latin America, 
Eastern Europe, northern India, and Japan[9-13]. The highest 
mortality rate of  gallbladder carcinoma in the world, 35 
per 100 000 inhabitants, is found in Southern Chile[9]. 
Japanese standardized mortality rates for gallbladder 
carcinoma were world’s second highest for males and 
fifth highest for females in 1996 with a steady increase in 
incidence (up to 5 per 100 000)[9,10,14]. On the other hand, 
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Zatonski reported that Hungarian mortality rates of  this 
tumor were the highest in Europe (4 per 100 000 males and 
7 per 100 000 females)[13]. This marked geographic variation 
implies that a combination of  genetic and environmental 
etiologic factors affects the process of  carcinogenesis of  
the gallbladder[10]. Previously, we revealed the geographic 
variation of  gallbladder carcinogenesis between Japan and 
Chile (a representative of  Latin American countries), both 
of  which were known as distinct high-incidence countries, 
in terms of  the p53 mutational spectra[14]. Only a few other 
investigators also have reported such geographic and 
ethnic differences in genetic changes of  this tumor[15-17]. 
Thus, there has been a paucity of  evidence regarding 
the geographic diversity of  genetic changes involved in 
gallbladder carcinogenesis.
The aim of  this study was to disclose geographic 
differences in genetic changes involved in gallbladder 
carcinogenesis by comparing gallbladder carcinomas from 
two distinct high-incidence areas, Japan and Hungary 
(a representative country of  Eastern Europe), in terms 
of  p53 mutations, K-ras mutations, and microsatellite 
instability (MSI).
MATERIALS AND METHODS
Tissue specimens
From 1982 to 1996, 22 patients with gallbladder carcinoma 
underwent a resection at Niigata University General 
Hospital and its affiliated institutions in Niigata Prefecture; 
the surgical specimens were collected and stored (Japanese 
cases). All the patients were Japanese. The Japanese cases 
in this study were identical with the Japanese cases in our 
previous study[14]. From 1982 to 2001, 20 patients with 
gallbladder carcinoma underwent a resection in hospitals in 
Budapest, Hungary; the surgical specimens were collected 
and stored (Hungarian cases) through the courtesy of  
a Hungarian oncologist (I.L.) and surgical pathologist 
(Z.S.). All the patients were residents in Budapest. Both 
the Japanese cases and the Hungarian cases (a total of  42 
cases) formed the basis of  this retrospective study. All 
of  the patients gave informed consent for pathologically 
examining the specimens. No patient in this series was 
diagnosed with anomalous union of  the pancreatic and 
biliary ducts (AUPBD), and had a family history suggestive 
of  hereditary nonpolyposis colorectal cancer (HNPCC).
The surgical specimens were fixed in formalin 
and embedded in paraffin. One or two representative 
sections of  each specimen were used for DNA analysis. 
Histopathological findings were described according to the 
tumor-node-metastasis (TNM) staging system[18].
DNA preparation
Five serial slices 10-μm thick were cut from each represen-
tative histologic section and deparaffinized. Cancer tissue 
in each slice was dissected under microscopic guidance 
as described previously[14]. Non-neoplastic tissue in each 
slice was used as a source of  constitutional DNA. DNA 
was extracted using a DNA Isolator PS Kit (Wako Pure 
Chemical Industries, Ltd., Osaka, Japan) as described 
previously[14].
Analysis of p53 mutations
p53 mutations at exons 5 to 8 were tested by nested 
polymerase chain reaction (PCR) and direct sequencing as 
described previously[14].
Analysis of K-ras mutations
K-ras mutations at codon 12 were tested by nested PCR, 
PCR-restriction fragment length polymorphism, and direct 
sequencing as described elsewhere[19].
Analysis of MSI
Fluorescent dye-labeled PCR amplification was performed 
using the five microsatellite markers (BAT-25, BAT-26, 
D2S123, D5S346, and D17S250) recommended by the 
National Cancer Institute workshop[20,21]. Fluorescent 
dye-labeled and unlabeled primers were obtained 
(Applied Biosystems Japan Ltd., Tokyo, Japan); the 
5' oligonucleotide was end-labeled with 6FAM (BAT-25, 
D2S123), VIC (BAT-26, D17S250), or NED (D5S346) 
fluorescent dyes. Amplification by PCR was performed 
using the Temp Control System PC-700 (ASTEC 
Co., Ltd., Fukuoka, Japan) in 30-μL reaction volumes 
containing 100 ng of  DNA, 0.75 U of  AmpliTaq Gold 
(Applied Biosystems Japan Ltd.), and 10 pmol of  each 
primer. The cycling profile was: denaturation at 95℃ for 
2 min, annealing at 55℃ for 40 s and extension at 72℃ 
for 40 s followed by a 7-min final extension step. A 1.0-μL 
aliquot of  each fluorescent dye-labeled PCR product 
was combined with 12 μL of  formamide and 0.5 μL 
of  the GENESCAN 350 [ROX] size standard (Applied 
Biosystems Japan Ltd.) and analyzed on an ABI PRISM 
310 Genetic Analyzer using GeneScan Analysis Software 
(Applied Biosystems Japan Ltd.). MSI experiments were 
repeated twice to exclude the possibility of  a false positive 
result due to PCR amplification artifacts in an independent 
PCR reaction. The sequencing results were verified by a 
second independently generated PCR product.
The presence of  MSI was determined from the 
PCR amplifications of  the five-microsatellite markers. 
Microsatellite instability was defined as the presence 
of  novel peaks that were not found in non-neoplastic 
tissue (Figure 1). A tumor was defined as having high 
microsatellite instability (MSI-high) if  more than one of  
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Figure 1  Fragment pattern of case No 1 (Table 1) showing microsatellite instability 
at two loci (BAT25, BAT26). N: Normal DNA; T: Tumor DNA. 
the five loci analyzed showed unequivocal instabilities; 
a tumor was defined as having low microsatel l i te 
instability (MSI-low) if  only one locus showed instability; 
and a tumor was defined as microsatellite stable if  no 
microsatellite instability was found. In this study, MSI-low 
tumors and microsatellite-stable tumors were categorized 
together into one group (MSI-low/none), as proposed by 
recent authors[16,22].
Statistical analysis
Fisher's exact test was used to compare the frequencies of  
genetic alterations between the two groups. All statistical 
evaluations were performed using the SPSS 11.5J software 
package (SPSS Japan Inc., Tokyo, Japan). All tests were 
two-sided and a P value < 0.05 was considered statistically 
significant.
RESULTS
p53 mutation
Mutations of  p53 at exons 5 to 8 were detected in 11 of  
22 (50.0%) Japanese cases and 6 of  18 (33.3%) Hungarian 
cases (P = 0.348; Table 1). Among the 17 cases with p53 
mutations, transversion was found in 4 of  11 Japanese 
cases and 1 of  6 Hungarian cases (P = 0.600). Transition 
at CpG sites was found in none of  11 Japanese cases and 
2 of  6 Hungarian cases; the difference was marginally 
significant (P = 0.110).
K-ras mutation
K-ras mutations at codon 12 were detected in none of  22 
Japanese cases and 1 of 20 Hungarian cases (P = 0.476) (Table 1).
MSI
Eight of  19 (42.1%) Japanese cases were MSI-high, whereas 
only one of  15 (6.7%) Hungarian cases was MSI-high; the 
difference was statistically significant (P = 0.047; Table 1).
Association between p53 mutation and MSI in gallbladder 
carcinoma
Both p53 mutation and MSI were analyzed successfully in 34 
cases: 19 Japanese cases and 15 Hungarian cases (Table 1). 
When the cases were stratified into Japanese cases and 
Hungarian cases, p53 mutations were not associated 
significantly with MSI in both groups. In all 34 cases, p53 
mutations were associated significantly with MSI (Table 2; 
P = 0.033).
DISCUSSION
Although earlier epidemiologic studies have suggested 
that the incidence of  gallbladder carcinoma varies 
geographically or ethnically[9,10], there is a paucity of  
evidence regarding the geographic diversity of  molecular 
changes associated with this tumor[7,8]. This prompted us 
to conduct the current study. In 1998, we reported that the 
p53 mutational spectra of  gallbladder carcinoma differed 
considerably between Japan and Chile, both of  which 
were known as high-incidence countries[14]. The current 
study first demonstrates that the process of  gallbladder 
carcinogenesis differs in terms of  p53 mutations and 
microsatellite instability between two distinct high-
incidence areas: Japan and Hungary (a representative 
country of  Eastern Europe).
Reported prevalences of  p53 mutation for gallbladder 
carcinoma ranged from 31% to 70%[14,23-26], suggesting that 
p53 mutation plays an important role in the development 
of  this tumor[8]. The prevalences of  p53 mutation in this 
series (50% in Japanese cases and 33% in Hungarian 
cases) are comparable with the reported figures. In various 
malignancies, endogenous carcinogenesis is characterized 
by transitions at CpG sites, whereas transversions imply 
the presence of  an exogenous mutational process[27-29]. 
In our previous study, the prevalence of  transitions at 
CpG sites was significantly higher in the Chilean cases 
than in the Japanese cases[14]. In the current study, there 
was a trend toward a higher prevalence of  transitions at 
CpG sites in the Hungarian cases. Taken together, these 
observations suggest that an endogenous mutational 
process contributed considerably to carcinogenesis of  
the gallbladder in the Chilean and Hungarian cases. In 
contrast, considering that there were no transitions at 
CpG sites and four transversions in the Japanese cases, it 
appears that exogenous mutations often happen during the 
process of  carcinogenesis in the Japanese cases. Therefore, 
geographic variation might exist in carcinogenesis of  the 
gallbladder among three distinct areas.
Reported prevalences of  K-ras mutation for gallbladder 
carcinoma without AUPBD ranged from 0% to 17%[16,30-33], 
suggesting that frequency of  K-ras mutation is relatively 
low in gallbladder carcinoma without AUPBD. This is 
consistent with our results: K-ras mutation was found in 
only one of  the Hungarian cases. Taken together, most 
gallbladder carcinoma appears to develop from a K-ras-
independent pathway.
M i c r o s a t e l l i t e i n s t ab i l i t y, wh i ch r e p r e s en t s 
replication errors, results from DNA mismatches due 
to environmental or hereditary factors and leads to 
genomic instability[34,35]. Reported prevalences of  MSI-
high for sporadic gallbladder carcinoma range from 0% to 
10%[15,16,36-38], whereas the prevalence was high (42.1%) in 
our cases. This suggests that environmental or hereditary 
factors contribute to carcinogenesis of  the gallbladder in 
some of  our cases. In the current study, the prevalence 
of  MSI-high was significantly higher in the Japanese cases 
than in the Hungarian cases. Considering that there were 
no patients with HNPCC in this series, the above finding 
suggests that the high prevalence of  MSI-high in the 
Japanese cases may be due to environmental factors, which 
remain unknown.
There are inverse relationships between p53 mutations 
and MSI in colorectal cancer[39,40]. Regarding gallbladder 
carcinoma, earlier authors have failed to identify such 
relationships between p53 mutations and MSI[16,38]. In this 
study, p53 mutations were associated significantly with MSI 
in all cases. When the cases were stratified into Japanese 
cases and Hungarian cases, no such associations between 
p53 mutation and MSI were found, probably due to the 
small sample size. Taken together, the above observations 
suggest that the pathway of  carcinogenesis differs between 
the gallbladder and the colon and rectum.
The current study has limitations. Firstly, it was a 
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retrospective analysis of  a small number of  patients. 
Secondly, DNA preparation from paraffin-embedded 
tissue sections was unsuccessful in some patients. Thirdly, 
only limited clinical information was available in the 
Hungarian cases to protect the patients’ privacy. To our 
knowledge, however, this study demonstrates more clearly 
the geographic diversity of  gallbladder carcinogenesis than 
earlier reports[15-17].
In conclusion, it appears that the p53 mutations and 
MSI differ in patients with gallbladder carcinoma between 
two distinct high-incidence areas. Exogenous mutations 
1According to the tumor-node-metastasis (TNM) staging system[18]. PAP: Papillary carcinoma; AD: Adenocarcinoma; ND: Not detected; G1: Well differentiated; 
G2: Moderately differentiated; G3: Poorly differentiated.
Case No Age (yr) Sex      Histology1                  p53 mutation K-ras  mutation Microsatellite instability
Type Grade Exon/codon Base change Base change
Japanese cases
1 71 F PAP G1 None - None BAT25, BAT26
2 74 F AD G1 Exon 5/codon 132 AAG to GAG None BAT25, D2S123
3 62 F PAP G1 None - None BAT25
4 76 F AD G1 Exon 6/codon 193 CAT to AAT None BAT25, BAT26
5 78 F AD G2 Exon 5/codon 140 ACC to ATC None ND
Exon 5/codon 166 TCA to ACA
6 70 F AD G1 Exon 8/codon 276 GCC to CCC None None
7 71 F AD G1 None - None BAT26, D2S123
8 79 F AD G1 None - None None
9 66 F PAP G1 None - None None
10 60 F PAP G1 None - None None
11 80 M PAP G1 None - None BAT26
12 63 M PAP G1 Exon 8/codon 294 GAG to GAA None BAT25, BAT26
13 49 F PAP G1 None - None D2S123
14 71 M AD G2 Exon 8/codon 280 AGA to AAA None BAT25, D2S123
15 70 M AD G1 Exon 7/codon 238 TGT to CGT None ND
16 53 M AD G1 None - None None
17 79 F AD G3 Exon 8/codon 271 GAG to AAG None None
18 62 M AD G3 Exon 6/codon 205 TAT to TGT None None
19 61 M AD G1 None - None D17S250, D2S123
20 69 M AD G2 Exon 7/codon 231 ACC to ATC None BAT25, D17S250
21 58 F AD G2 Exon 5/codon 160 ATG to GTG None ND
Exon 6/codon 220 TAT to AAT
22 76 F AD G3 None - None None
Hungarian cases
23 71 M AD G2 Exon 7/codon 249 AGG to ACG None BAT26
24 69 F AD G3 Exon 6/codon 213 CAG to CGG None None
25 69 F AD G2 None - None None
26 76 F AD G2 None - None None
27 61 F AD G3 None - None None
28 58 F AD G3 None - None BAT25
29 69 F AD G3 None - None None
30 75 F PAP G1 None - None None
31 66 F AD G3 None - None None
32 65 F AD G1 Exon 6/codon 219 CCC to TCC None ND
33 61 F AD G3 ND - None ND
34 Unknown F PAP G1 Exon 5/codon 138 GCC to GCT None BAT25, D17S250
Exon 5/codon 167 CAG to CAA
Exon 5/codon 170 ACG to ACA
35 Unknown F PAP G1 Exon 5/codon 158 CGC to TGC GGT to AGT ND
Exon 6/codon 223 CCT to TCT
36 Unknown F AD G3 Exon 6/codon 210 AAC to AAT None ND
Exon 7/codon 228 GAC to AAC
37 Unknown F AD G2 ND - None ND
38 53 F AD G3 None - None None
39 72 Unknown AD G1 None - None None
40 69 M AD G1 None - None BAT26
41 57 F AD G1 None - None None
42 74 F AD G1 None - None BAT25
Table 1  Genetic alterations observed in gallbladder carcinomas from Japan and Hungary
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MSI-high MSI-low/none   P
p53  mutation Present        6           5 0.033
Absent        3         20
Table 2  Association between p53 mutation and MSI in gallbladder 
carcinoma
MSI: Microsatellite instability.
and unknown environmental factors may play roles in 
gallbladder carcinogenesis in the Japanese cases, whereas 
the Hungarian cases are characterized by an endogenous 
mutational process. Thus, geographic variation might exist 
in the process of  gallbladder carcinogenesis.
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 COMMENTS
Background
Although considerable progress has been made regarding the molecular 
pathogenesis of human neoplasms, there is only limited information about the 
genetic changes involved in gallbladder carcinogenesis. Gallbladder carcinoma 
shows striking geographic and ethnic variation, however there is a paucity of 
evidence regarding the geographic diversity of molecular changes associated with 
this tumor.
Research frontiers
In 1998, we reported that the p53 mutational spectra of gallbladder carcinoma 
differed considerably between Japan and Chile, both of which were known as 
high-incidence countries. Only a few other investigators also have reported such 
geographic and ethnic differences in genetic changes of this tumor. The aim of 
this study was to disclose geographic differences in genetic changes involved in 
gallbladder carcinogenesis by comparing gallbladder carcinomas from two distinct 
high-incidence areas, Japan and Hungary.
Innovations and breakthroughs
The current study first demonstrates that the p53 mutations and MSI differ in 
patients with gallbladder carcinoma between two distinct high-incidence areas: 
Japan and Hungary. Exogenous mutations and unknown environmental factors 
may play roles in gallbladder carcinogenesis in the Japanese cases, whereas the 
Hungarian cases are characterized by an endogenous mutational process. Thus, 
geographic variation might exist in the process of gallbladder carcinogenesis.
Applications 
Gallbladder carcinoma is a highly lethal disease with a poor prognosis. Therefore, 
it would be very beneficial to identify the molecular mechanism responsible for this 
condition. Advances in the understanding of the genetic changes of this tumor will 
help in understanding the pathogenesis of this miserable disease.
Terminology
Microsatellite instability (MSI) is caused by a failure of the DNA mismatch 
repair system to repair errors that occur during the replication of DNA and is 
characterized by the accelerated accumulation of single nucleotide mutations and 
alterations in the length of simple, repetitive microsatellite sequences that occur 
ubiquitously throughout the genome. MSI is seen in most HNPCC tumors and 
proportion of nonhereditary colorectal tumors. The presence of MSI in tumor tissue 
is associated with certain unique clinical and pathological characteristics.
Peer review
This study aimed to determine the difference of some genetic changes involved in 
gallbladder carcinogenesis in high-prevalence areas of Japan and Hungary. This 
is a well written paper and has a nice finding. While it is simply an observational 
study, I think it is an important observation.
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